Deschloroclotizolam

Deschloroclotizolam(Clotizolam-2) is a benzodiazepine drug, a derivative of thienotriazolodiazepine, with sedative and anxiolytic effects. This drug was first discovered in Sweden (EU) in 2021, as a new designer drug for chemical research.
Studies have shown that Deschloroclotizolam actively affects GABA receptors, causing sedative and anxiolytic effects.

Unique properties

-Incredibly powerful sedative effect.
-The active metabolite of clotizolam.
– Unlike most benzodiazepine, Deschloroclotizolam has a unique pharmacological profile. The action of this drug makes it a unique research tool for exploring potential therapeutic benefits and side effects.